ArticleTransplantation direct2020

The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation.

Seiichiro Tada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.